Morpholino

MO1-slc2a1a

ID
ZDB-MRPHLNO-060608-3
Name
MO1-slc2a1a
Previous Names
  • MO1-slc2a1
  • glut1 start MO
Target
Sequence
5' - GGCCATCATCAGCTGAGGAGTCACC - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-slc2a1a
Expressed Gene Anatomy Figures
slc2a1a Fig. 7 from Jensen et al., 2010
Phenotype
Phenotype resulting from MO1-slc2a1a
Phenotype Fish Figures
brain compartment boundary amorphous, abnormal WT + MO1-slc2a1a Fig. 3,  Fig. 7 from Jensen et al., 2006
central nervous system morphology, abnormal WT + MO1-slc2a1a Fig. 3,  Fig. 7 from Jensen et al., 2006
central nervous system apoptotic process increased occurrence, abnormal WT + MO1-slc2a1a Fig. 4 from Carayannopoulos et al., 2014
Fig. 6 from Jensen et al., 2006
extension decreased size, abnormal WT + MO1-slc2a1a Fig. 3 from Jensen et al., 2006
extension decreased thickness, abnormal WT + MO1-slc2a1a Fig. 3 from Jensen et al., 2006
extension morphology, abnormal WT + MO1-slc2a1a Fig. 7 from Jensen et al., 2006
fourth ventricle increased size, abnormal WT + MO1-slc2a1a Fig. 3,  Fig. 7 from Jensen et al., 2006
glucose import decreased rate, abnormal WT + MO1-slc2a1a Fig. 4 from Jensen et al., 2010
Fig. 6,  Fig. 7 from Jensen et al., 2006
head opaque, abnormal WT + MO1-slc2a1a Fig. 1 from Jensen et al., 2010
Fig. 3,  Fig. 7 from Jensen et al., 2006
lateral longitudinal fasciculus axonal fasciculation decreased process quality, abnormal WT + MO1-slc2a1a Fig. 5 from Jensen et al., 2006
macrophage phagocytosis decreased occurrence, abnormal gl22Tg + MO1-slc2a1a Fig. 3 with image from Morioka et al., 2018
medial longitudinal fasciculus axonal fasciculation decreased process quality, abnormal WT + MO1-slc2a1a Fig. 5 from Jensen et al., 2006
median fin fold morphology, abnormal WT + MO1-slc2a1a Fig. 3 from Jensen et al., 2006
midbrain hindbrain boundary absent, abnormal WT + MO1-slc2a1a Fig. 3 from Jensen et al., 2006
midbrain hindbrain boundary decreased size, abnormal WT + MO1-slc2a1a Fig. 5 from Jensen et al., 2006
tectal ventricle increased size, abnormal WT + MO1-slc2a1a Fig. 3 from Jensen et al., 2006
trigeminal ganglion neuron decreased amount, abnormal WT + MO1-slc2a1a Fig. 5 from Jensen et al., 2006
white matter disorganized, abnormal WT + MO1-slc2a1a Fig. 5 from Jensen et al., 2006
whole organism dead, abnormal WT + MO1-slc2a1a text only from Jensen et al., 2006
whole organism apoptotic process increased occurrence, abnormal WT + MO1-slc2a1a Fig. 4 from Carayannopoulos et al., 2014
Fig. 6,  Fig. S6 from Jensen et al., 2006
Phenotype of all Fish created by or utilizing MO1-slc2a1a
Phenotype Fish Conditions Figures
white matter disorganized, abnormal WT + MO1-slc2a1a standard conditions Fig. 5 from Jensen et al., 2006
extension morphology, abnormal WT + MO1-slc2a1a standard conditions Fig. 7 from Jensen et al., 2006
whole organism apoptotic process increased occurrence, abnormal WT + MO1-slc2a1a standard conditions Fig. 4 from Carayannopoulos et al., 2014
Fig. 6,  Fig. S6 from Jensen et al., 2006
midbrain hindbrain boundary absent, abnormal WT + MO1-slc2a1a standard conditions Fig. 3 from Jensen et al., 2006
head opaque, abnormal WT + MO1-slc2a1a standard conditions Fig. 1 from Jensen et al., 2010
Fig. 3,  Fig. 7 from Jensen et al., 2006
glucose import decreased rate, abnormal WT + MO1-slc2a1a standard conditions Fig. 4 from Jensen et al., 2010
Fig. 6,  Fig. 7 from Jensen et al., 2006
central nervous system apoptotic process increased occurrence, abnormal WT + MO1-slc2a1a standard conditions Fig. 4 from Carayannopoulos et al., 2014
Fig. 6 from Jensen et al., 2006
medial longitudinal fasciculus axonal fasciculation decreased process quality, abnormal WT + MO1-slc2a1a standard conditions Fig. 5 from Jensen et al., 2006
brain compartment boundary amorphous, abnormal WT + MO1-slc2a1a standard conditions Fig. 3,  Fig. 7 from Jensen et al., 2006
fourth ventricle increased size, abnormal WT + MO1-slc2a1a standard conditions Fig. 3,  Fig. 7 from Jensen et al., 2006
extension decreased thickness, abnormal WT + MO1-slc2a1a standard conditions Fig. 3 from Jensen et al., 2006
whole organism dead, abnormal WT + MO1-slc2a1a standard conditions text only from Jensen et al., 2006
extension decreased size, abnormal WT + MO1-slc2a1a standard conditions Fig. 3 from Jensen et al., 2006
trigeminal ganglion neuron decreased amount, abnormal WT + MO1-slc2a1a standard conditions Fig. 5 from Jensen et al., 2006
lateral longitudinal fasciculus axonal fasciculation decreased process quality, abnormal WT + MO1-slc2a1a standard conditions Fig. 5 from Jensen et al., 2006
median fin fold morphology, abnormal WT + MO1-slc2a1a standard conditions Fig. 3 from Jensen et al., 2006
midbrain hindbrain boundary decreased size, abnormal WT + MO1-slc2a1a standard conditions Fig. 5 from Jensen et al., 2006
central nervous system morphology, abnormal WT + MO1-slc2a1a standard conditions Fig. 3,  Fig. 7 from Jensen et al., 2006
tectal ventricle increased size, abnormal WT + MO1-slc2a1a standard conditions Fig. 3 from Jensen et al., 2006
macrophage phagocytosis decreased occurrence, abnormal gl22Tg + MO1-slc2a1a control Fig. 3 with image from Morioka et al., 2018
central nervous system morphology, ameliorated WT + MO1-badb + MO1-slc2a1a standard conditions Fig. 7 from Jensen et al., 2006
brain compartment boundary morphology, ameliorated WT + MO1-badb + MO1-slc2a1a standard conditions Fig. 7 from Jensen et al., 2006
extension morphology, ameliorated WT + MO1-badb + MO1-slc2a1a standard conditions Fig. 7 from Jensen et al., 2006
fourth ventricle size, ameliorated WT + MO1-badb + MO1-slc2a1a standard conditions Fig. 7 from Jensen et al., 2006
glucose import decreased rate, abnormal WT + MO1-badb + MO1-slc2a1a standard conditions Fig. 7 from Jensen et al., 2006
whole organism apoptotic process occurrence, ameliorated WT + MO1-badb + MO1-slc2a1a standard conditions Fig. S6 from Jensen et al., 2006
central nervous system morphology, ameliorated WT + MO1-slc2a1a + MO2-badb standard conditions Fig. 7 from Jensen et al., 2006
brain compartment boundary morphology, ameliorated WT + MO1-slc2a1a + MO2-badb standard conditions Fig. 7 from Jensen et al., 2006
extension morphology, ameliorated WT + MO1-slc2a1a + MO2-badb standard conditions Fig. 7 from Jensen et al., 2006
fourth ventricle size, ameliorated WT + MO1-slc2a1a + MO2-badb standard conditions Fig. 7 from Jensen et al., 2006
glucose import decreased rate, abnormal WT + MO1-slc2a1a + MO2-badb standard conditions Fig. 7 from Jensen et al., 2006
whole organism apoptotic process occurrence, ameliorated WT + MO1-slc2a1a + MO2-badb standard conditions Fig. S6 from Jensen et al., 2006
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.